127 related articles for article (PubMed ID: 1714667)
21. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
Seitz H; Schmitt M; Böhmer G; Kopp-Schneider A; Müller M
Int J Cancer; 2013 Feb; 132(3):E139-48. PubMed ID: 22961598
[TBL] [Abstract][Full Text] [Related]
22. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
Huber B; Schellenbacher C; Shafti-Keramat S; Jindra C; Christensen N; Kirnbauer R
PLoS One; 2017; 12(1):e0169533. PubMed ID: 28056100
[TBL] [Abstract][Full Text] [Related]
23. Expression of the human papillomavirus type 6b L2 open reading frame in Escherichia coli: L2-beta-galactosidase fusion proteins and their antigenic properties.
Tomita Y; Shirasawa H; Sekine H; Simizu B
Virology; 1987 May; 158(1):8-14. PubMed ID: 2437699
[TBL] [Abstract][Full Text] [Related]
24. Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies.
Jin XW; Cowsert LM; Pilacinski WP; Jenson AB
J Gen Virol; 1989 May; 70 ( Pt 5)():1133-40. PubMed ID: 2471804
[TBL] [Abstract][Full Text] [Related]
25. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
26. Mapping of linear B cell epitopes on capsid proteins of bovine papillomavirus: identification of three external type-restricted epitopes.
Cason J; Kambo PK; Jewers RJ; Chrystie IL; Best JM
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2669-77. PubMed ID: 8277272
[TBL] [Abstract][Full Text] [Related]
27. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA
Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551
[TBL] [Abstract][Full Text] [Related]
28. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes.
Roden RB; Yutzy WH; Fallon R; Inglis S; Lowy DR; Schiller JT
Virology; 2000 May; 270(2):254-7. PubMed ID: 10792983
[TBL] [Abstract][Full Text] [Related]
29. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of antibodies to human papillomavirus type 8 in human sera.
Steger G; Olszewsky M; Stockfleth E; Pfister H
J Virol; 1990 Sep; 64(9):4399-406. PubMed ID: 2166821
[TBL] [Abstract][Full Text] [Related]
31. Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.
Jenison SA; Firzlaff JM; Langenberg A; Galloway DA
J Virol; 1988 Jun; 62(6):2115-23. PubMed ID: 2835513
[TBL] [Abstract][Full Text] [Related]
32. Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein.
Sapp M; Kraus U; Volpers C; Snijders PJ; Walboomers JM; Streeck RE
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3375-83. PubMed ID: 7996132
[TBL] [Abstract][Full Text] [Related]
33. Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2.
Volpers C; Sapp M; Snijders PJ; Walboomers JM; Streeck RE
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2661-7. PubMed ID: 7595373
[TBL] [Abstract][Full Text] [Related]
34. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.
Wikström A; Eklund C; Von Krogh G; Lidbrink P; Dillner J
J Clin Microbiol; 1992 Jul; 30(7):1795-800. PubMed ID: 1378454
[TBL] [Abstract][Full Text] [Related]
35. Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles.
Zhou J; Sun XY; Davies H; Crawford L; Park D; Frazer IH
Virology; 1992 Aug; 189(2):592-9. PubMed ID: 1379392
[TBL] [Abstract][Full Text] [Related]
36. Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins.
Buonamassa DT; Greer CE; Capo S; Yen TS; Galeotti CL; Bensi G
Virology; 2002 Feb; 293(2):335-44. PubMed ID: 11886254
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products.
Köchel HG; Sievert K; Monazahian M; Mittelstädt-Deterding A; Teichmann A; Thomssen R
Virology; 1991 Jun; 182(2):644-54. PubMed ID: 1850922
[TBL] [Abstract][Full Text] [Related]
39. Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.
Combita AL; Touzé A; Bousarghin L; Christensen ND; Coursaget P
J Virol; 2002 Jul; 76(13):6480-6. PubMed ID: 12050360
[TBL] [Abstract][Full Text] [Related]
40. HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts.
Carter JJ; Hagensee M; Taflin MC; Lee SK; Koutsky LA; Galloway DA
Virology; 1993 Aug; 195(2):456-62. PubMed ID: 7687802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
